This appears to be a great device since it will allow people to get treatment sooner.
Technions NaNose catches lung cancer 90% of the time
The nanotech-based detection system is ready for the market, based on the results of a study by researchers
BY DAVID SHAMAH June 19, 2014
A cancer-detection technology that sniffs out malignant tumors is set to be commercialized, after a study showed that a device based on the Technion-developed NaNose system successfully detected lung cancer in patients with up to 90 percent accuracy. At the heart of the device which looks like a breathalyzer, usually used to detect alcohol levels is a chip based on the NaNose technology
By detecting the special odor emitted by cancer cells the NaNose system can detect the presence of both benign and malignant tumors much more quickly, efficiently and cheaply, said Dr. Hossam Haick of the Technion, who helped develop the technology. Current cancer diagnosis techniques are ineffective and impractical. NaNose technology, he said, could facilitate faster therapeutic intervention, replacing expensive and time-consuming clinical follow-up that would eventually lead to the same intervention.
Read more:
Technion's NaNose catches lung cancer 90% of the time | The Times of Israel
Technions NaNose catches lung cancer 90% of the time
The nanotech-based detection system is ready for the market, based on the results of a study by researchers
BY DAVID SHAMAH June 19, 2014
A cancer-detection technology that sniffs out malignant tumors is set to be commercialized, after a study showed that a device based on the Technion-developed NaNose system successfully detected lung cancer in patients with up to 90 percent accuracy. At the heart of the device which looks like a breathalyzer, usually used to detect alcohol levels is a chip based on the NaNose technology
By detecting the special odor emitted by cancer cells the NaNose system can detect the presence of both benign and malignant tumors much more quickly, efficiently and cheaply, said Dr. Hossam Haick of the Technion, who helped develop the technology. Current cancer diagnosis techniques are ineffective and impractical. NaNose technology, he said, could facilitate faster therapeutic intervention, replacing expensive and time-consuming clinical follow-up that would eventually lead to the same intervention.
Read more:
Technion's NaNose catches lung cancer 90% of the time | The Times of Israel